GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Samchundang Pharm Co Ltd (XKRX:000250) » Definitions » Cyclically Adjusted Price-to-FCF

Samchundang Pharm Co (XKRX:000250) Cyclically Adjusted Price-to-FCF : (As of May. 02, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Samchundang Pharm Co Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Samchundang Pharm Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Samchundang Pharm Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samchundang Pharm Co Cyclically Adjusted Price-to-FCF Chart

Samchundang Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 75.98 211.60 241.92 900.12 -

Samchundang Pharm Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 900.12 16,708.34 - - -

Competitive Comparison of Samchundang Pharm Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Samchundang Pharm Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Samchundang Pharm Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Samchundang Pharm Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Samchundang Pharm Co's Cyclically Adjusted Price-to-FCF falls into.



Samchundang Pharm Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Samchundang Pharm Co's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Samchundang Pharm Co's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=710.319/118.8477*118.8477
=710.319

Current CPI (Dec. 2023) = 118.8477.

Samchundang Pharm Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 3.751 99.253 4.492
201406 133.581 99.353 159.792
201409 138.341 99.608 165.062
201412 145.806 99.098 174.864
201503 -208.746 99.720 -248.786
201506 130.545 100.050 155.072
201509 189.489 100.110 224.956
201512 184.525 100.220 218.822
201603 189.893 100.560 224.427
201606 201.000 100.790 237.011
201609 164.977 101.460 193.250
201612 -143.659 101.560 -168.113
201703 336.668 102.850 389.035
201706 151.196 102.610 175.122
201709 57.998 103.490 66.605
201712 270.074 102.990 311.658
201803 23.006 104.100 26.265
201806 119.521 104.130 136.414
201809 -73.583 105.650 -82.775
201812 168.209 104.350 191.579
201903 -156.546 104.490 -178.057
201906 378.796 104.880 429.243
201909 714.737 105.200 807.461
201912 16.752 105.120 18.940
202003 -115.546 105.540 -130.115
202006 -198.979 104.870 -225.500
202009 -85.675 106.200 -95.878
202012 2.700 105.765 3.034
202103 -346.652 107.357 -383.754
202106 -135.768 107.579 -149.990
202109 -661.550 108.759 -722.915
202112 -530.522 109.676 -574.885
202203 -606.118 111.806 -644.293
202206 -183.428 114.083 -191.089
202209 -215.469 114.831 -223.005
202212 -472.599 115.200 -487.563
202303 -304.398 116.550 -310.400
202306 -191.033 117.140 -193.818
202309 -177.640 119.111 -177.247
202312 710.319 118.848 710.319

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Samchundang Pharm Co  (XKRX:000250) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Samchundang Pharm Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Samchundang Pharm Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Samchundang Pharm Co (XKRX:000250) Business Description

Traded in Other Exchanges
N/A
Address
1606-1 SeoCho-Dong, SeoCho-Gu, Seoul, KOR, 137-877
Samchundang Pharm Co Ltd is engaged in manufacturing, distributing, importing, and exporting pharmaceuticals in South Korea. The company offers ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as gastro intestines and vitamins.

Samchundang Pharm Co (XKRX:000250) Headlines

No Headlines